The microbiology of central nervous system infections /
The Microbiology of Central Nervous System Infections, Volume 3, discusses modern approaches to the diagnosis, treatment and prophylaxis of central nervous system (CNS) infections. This new release is divided into five sections that cover treatment strategies, imaging, molecular diagnosis, managemen...
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
London :
Academic Press,
[2018]
|
Edición: | First edition. |
Colección: | Clinical microbiology diagnosis, treatment and prophylaxis of infections ;
3. |
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Front Cover; The Microbiology of Central Nervous System Infections; Copyright; Contents; Contributors; Preface; Section I: Central Nervous System Infections: Current Trends in Diagnosis, Treatment and Prophylaxis; Chapter 1: Meningitis: Current Understanding and Management; 1. Introduction; 2. Classification; 2.1. Viral Meningitis1-4; 2.1.1. Introduction; 2.1.2. Clinical Characteristics; 2.1.3. Clinical Presentation and Differential Diagnoses2-4; 2.1.4. Investigations2-4; 2.1.5. Management and Prognosis3,4; 2.2. Bacterial Meningitis4,5; 2.2.1. Introduction5,6; 2.2.2. Etiopathogenesis5-7
- 2.2.3. The Predisposing Risk Factors2.2.4. Clinical Presentation and Differential Diagnosis12; 2.2.5. Differential Diagnosis of Bacterial Meningitis; 2.2.6. Investigations5-8; 2.2.7. Management5-15; 2.2.8. Precautions to Prevent the Spread and Recurrence; 2.2.9. Prognosis: Morbidity and Mortality5-15; 2.3. Fungal Meningitis1,16; 2.3.1. Introduction; 2.3.2. Clinical Characteristics1,16-18; 2.3.3. Differential Diagnosis; 2.3.4. Management1,16,18,20; 2.4. Parasitic Meningitis25,26; 2.4.1. Introduction; 2.4.2. Clinical Etiopathologic Characteristics
- 2.4.3. Clinical Presentations and Their Management25-272.4.4. The Prognosis; 2.5. Chemical Meningitis28,29; 2.5.1. Introduction; 2.5.2. Etiopathogenesis; 2.5.3. Clinical Presentations; 2.5.4. Management and Prognosis; 2.6. Neoplastic/Carcinomatous Meningitis30,31; 2.6.1. Introduction; 2.6.2. General Characteristics; 2.6.3. Clinical Symptomatology30-32; 2.6.4. Diagnosis and Differential Diagnosis32; 2.6.5. Management and Prognosis30-32; 3. Conclusions1-4,10,11,16,25,27,28,32; References; Chapter 2: Pathogenesis, Diagnosis, and Treatment of Central Nervous System Catheter Infections
- 1. Introduction2. Hosts at Risk of Infection; 3. Microbiology; 3.1. Biofilm; 4. Immune Response; 4.1. Biofilm Evasion of Immune Response; 5. Symptoms of Infection; 6. Diagnosis of Infection; 7. Treatment; 8. Prevention; 9. Conclusions and Outstanding Questions; References; Chapter 3: Molecular Diagnosis of CNS Viral Infections; 1. Introduction; 2. Techniques for the Diagnosis of Neuroviral Infections; 2.1. Neuroimaging; 2.2. Lumbar Puncture and CSF Analysis; 2.3. Serology; 2.4. Brain Biopsy; 2.5. Molecular Methodologies; 2.5.1. CSF Nucleic Acid Amplification Using Polymerase Chain Reaction
- 2.5.2. DNA Microarray2.5.3. Luminex Technology; 2.5.4. DNA Sequencing; 3. Patents on Molecular Diagnosis of CNS Viral Infections; 4. Future Scope for Diagnosis of CNS Viral Infections; References; Further Reading; Chapter 4: Vaccines Against Central Nervous System Infections: Past Achievements and Future Challenges; 1. Introduction; 2. Epidemiology of Meningitis; 3. Epidemiology of Encephalitis; 4. Vaccines Against H. influenzae; 5. Vaccines Against S. pneumoniae; 6. Vaccines Against N. meningitidis; 7. Vaccines Against Measles and Mumps; 8. Conclusion; Declaration of Interests; References